Pttg1/securin is Required for the Branching Morphogenesis of the Mammary Gland and Suppresses Mammary Tumorigenesis

R. Hatcher,Jie Dong,Shuang Liu,Guangxing Bian,A. Contreras,Tao Wang,S. Hilsenbeck,Yi Li,Pumin Zhang

DOI: https://doi.org/10.1073/pnas.1318124111

2014-01-01

Abstract:Significance Pituitary tumor transforming gene 1 (Pttg1) has been suggested as an oncogene. Here we show that it could act as a tumor suppressor, at least in mammary glands. Loss of Pttg1 leads to spontaneous mammary gland tumorigenesis, whereas, in human breast tumors, there is a significant inverse correlation between the expression levels of PTTG1 and the tumor grade. This tumor suppressor function of Pttg1 is likely rooted in its role in the regulation of the proliferation of mammary gland epithelial cells and the morphogenesis of the ductal trees of the gland. We demonstrated that a number of genes related to proliferation and mammary gland branching morphogenesis were misregulated in the absence of Pttg1, which provides in vivo evidence that PTTG1 regulates gene expression. Pituitary tumor transforming gene 1 (Pttg1) encodes the mammalian securin, which is an inhibitor of separase (a protease required for the separation of sister chromatids in mitosis and meiosis). PTTG1 is overexpressed in a number of human cancers and has been suggested to be an oncogene. However, we found that, in Pttg1-mutant females, the mammary epithelial cells showed increased proliferation and precocious branching morphogenesis. In accord with these phenotypic changes, progesterone receptor, cyclin D1, and Mmp2 were up-regulated whereas p21 (Cdkn1a) was down-regulated. These molecular changes provide explanation for the observed developmental defects, and suggest that Pttg1 is a tumor suppressor. Indeed, mice lacking Pttg1 developed spontaneous mammary tumors. Furthermore, in human breast tumors, PTTG1 protein levels were down-regulated and the reduction was significantly correlated with the tumor grade.